Tetrahydromagnolol

Overview

Tetrahydromagnolol (Magnolignan), the main metabolite of Magnolol, is a potent and selective cannabinoid CB2 receptor agonist ( EC 50 =170 nM) and GPR55 antagonist. The K i of Tetrahydromagnolol for CB2 is 416 nM, 20-fold higher than for the CB1 receptor. Magnolol shows antifungal , anti-inflammatory and analgesic effects.

Application

Products | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Cannabinoid Receptor | Products > Signaling Pathways > GPR55 | Products > Signaling Pathways > Drug Metabolite

Product Information

• Catalog No.: HY-116637
• CAS No.: 20601-85-8
• Molecular Formula: C18H22O2
• Molecular Weight: 270.37
• Purity: 99.89%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (9.25 mM); Clear solution
• Availability: In-stock

Source

Original product source